Midazolam in treatment of epileptic seizures
- PMID: 1622519
- DOI: 10.1016/0887-8994(92)90071-6
Midazolam in treatment of epileptic seizures
Abstract
Midazolam (Versed), the first water-soluble benzodiazepine, has had widespread acceptance as a parenteral anxiolitic agent. Its antiepileptic properties were studied in adult patients with good results. Midazolam was administered intramuscularly to 48 children, ages 4 months to 14 years, with 69 epileptic episodes of various types. In all but 5 epileptic episodes, seizures stopped 1-10 min after injection. These results suggest that midazolam administered intramuscularly may be useful in a variety of epileptic seizures during childhood, specifically when attempts to introduce an intravenous line in convulsing children are unsuccessful.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
